Halozyme Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
HALO | B | Halozyme Therapeutics, Inc. | 13.01 | |
NXTC | F | NextCure, Inc. | 0.38 |
Related Industries: Biotechnology
Related Stock Lists:
Biopharmaceutical
Solid Tumors
Antibodies
Biotechnology
Cancer
Cancer Treatment
Clinical Development
Clinical Medicine
Clinical Trial Product
Diabetes
Diabetes Mellitus
Enzymes
Hoffmann La Roche
Hyaluronidase
Immune Related Diseases
Immunotherapy
Insulin
Intrexon
Life Sciences
Medicine
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
FBT | A | First Trust Amex Biotech Index Fund | 3.18 | |
CSMD | D | Congress SMid Growth ETF | 2.39 | |
PBE | C | PowerShares Dynamic Biotech & Genome | 2.32 | |
GSC | D | Goldman Sachs Small Cap Core Equity ETF | 1.55 | |
BBP | A | BioShares Biotechnology Products Fund | 1.47 |
Compare ETFs
Related Industries:
Biotechnology
Related Stock Lists:
Biopharmaceutical
Solid Tumors
Antibodies
Biotechnology
Cancer
Cancer Treatment
Clinical Development
Clinical Medicine
Clinical Trial Product
Diabetes
Diabetes Mellitus
Enzymes
Hoffmann La Roche
Hyaluronidase
Immune Related Diseases
Immunotherapy
Insulin
Intrexon
Life Sciences
Medicine
- Halozyme
Halozyme Therapeutics is a U.S. biotechnology company that develops novel oncology therapies designed to target the tumor microenvironment and licenses a novel drug delivery technology through corporate partnerships.
The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California.
Popular Now
Recent Comments
- Cos3 on Adding float as advanced filter criteria?
- FriendlyOyster657 on BOOT
- TraderMike on Filtering by News?
- Dr_Duru on Filtering by News?
- TraderMike on Filtering by News?
From the Blog
Featured Articles